A
$ Value
$0
Shares
65,124
Price
$0
Filed
Apr 7
Insider
Name
Stauderman Kenneth A.
Title
Chief Scientific Officer
CIK
0001969388
Roles
Officer
Transaction Details
Transaction Date
2025-04-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
65,124
Footnotes
Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual "evergreen" provision.
Filing Info
Stauderman Kenneth A.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-28 | CALC | ▲ | $4K ★ |
| 2025-07-25 | CALC | ▼ | $4K |
| 2025-07-01 | CALC | ▲ | $2K |
| 2025-06-24 | CALC | A | $0 |
| 2025-04-23 | CALC | A | $0 |
| 2025-04-05 | CALC | A | $0 |
Other Insiders at CALC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
|
— | — | 2025-04-05 |
|
Roberts Eric W
CHIEF BUSINESS OFFICER
|
— | — | 2025-04-05 |
|
Bardin Stephen
Chief Financial Officer
|
— | — | 2025-04-05 |
|
Dunn Michael J.
President and COO
|
— | — | 2025-04-05 |
|
Hebbar Sudarshan
Chief Medical Officer
|
— | — | 2025-04-05 |